Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    NEURAMINIDASE DEFICIENCY
Show Display Options
Rank Status Study
1 Recruiting Longitudinal Studies of the Glycoproteinoses
Conditions: Aspartylglucosaminuria;   Fucosidosis;   Galactosialidosis;   Alpha Mannosidosis;   Beta Mannosidosis;   Mucolipidosis II;   Mucolipidosis III;   Schindler Disease;   Sialidosis
2 Completed Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: disodium clodronate 200 mg/4 ml with 1% lidocaine;   Drug: Disodium clodronate 100 mg/3,3 ml with 1% lidocaine

Indicates status has not been verified in more than two years